Latest Causes of schizophrenia Stories
WATERTOWN, Mass., Jan. 5 /PRNewswire/ -- EnVivo Pharmaceuticals today announced the initiation and dosing of patients in a Phase 2b study of its EVP-6124 compound, a selective alpha-7 nicotinic agonist in patients with schizophrenia.
Researchers Use Biomarkers to Identify Emerging Illness at Early Stage.
Researchers at the Swedish medical university Karolinska Institutet have discovered that patients with recent-onset schizophrenia have higher levels of inflammatory substances in their brains.
A new study by researchers at the Institute of Psychiatry (IoP), King's College London has discovered abnormalities in the white matter of the brain that seem to be critical for the timing of schizophrenia.
Last year the UK government reclassified cannabis from a class C to a class B drug, partly out of concerns that cannabis, especially the more potent varieties, may increase the risk of schizophrenia in young people.
Schizophrenia is a major public health problem. Affecting almost 1% of the world's population, it takes an enormous economic and social toll in addition to the distress, dysfunction, disability and mortality for those afflicted with this disease.
Findings may help predict disease progression and provide opportunities for more targeted drug development to block mechanism.
22nd Congress of the European College of Neuropsychopharmacology (ECNP), 12 - 16 September 2009, Istanbul, Turkey
For the first time, an international group of researchers has found genetic evidence linking schizophrenia to a specific region of DNA â€“ on chromosome 6. This is the same area where key genes for immune function are located.
- In medieval musical notation, a sign or neume denoting a shake or trill.